<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03617419</url>
  </required_header>
  <id_info>
    <org_study_id>110.05-2017-GES-0001</org_study_id>
    <nct_id>NCT03617419</nct_id>
  </id_info>
  <brief_title>Vscan Access R2 Feasibility Evaluation</brief_title>
  <official_title>Evaluation of Feasibility and Accuracy of Assisted Fetal Heart Rate (FHR) Feature of the GE Vscan Access R2 Ultrasound System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being done to evaluate if the Vscan Access R2 Ultrasound System can measure
      Fetal Heart Rate (FHR) in humans when compared against a reference device (GE Corometrics 170
      Series Fetal Monitor), and to gather feedback from device operators on the usability of the
      device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is being done to evaluate whether the Vscan Access R2 Ultrasound System Assisted
      FHR phantom testing conclusions can be extrapolated onto human fetal heart rate measurements,
      where CTG (GE Corometrics 170 Series Fetal Monitor) is to provide a reference value. It
      should be noted that the Vscan Access R2 Ultrasound System with Assisted FHR has a different
      intended use than CTG (momentary FHR value versus continuous monitoring of FHR patterns and
      trends) and this aspect is out of scope of this research.

      Usability data will be gathered for further user experience optimization.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 14, 2017</start_date>
  <completion_date type="Actual">February 26, 2018</completion_date>
  <primary_completion_date type="Actual">November 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Sequential Assignment</intervention_model>
    <intervention_model_description>This study is being done to evaluate and gather feasibility data and user feedback on the use of the Vscan Access R2 device in vivo on pregnant volunteers in their 2nd and 3rd Trimester. The study will be conducted in two parts, including an initial pilot for determination of parameters (Part 1) and continued testing (Part 2).</intervention_model_description>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Fetal Heart Rate as Measured by VScan Access R2 and Corometrics</measure>
    <time_frame>1 day - Up to 45 minutes of total scan time</time_frame>
    <description>Absolute difference and variance in fetal heart rate (in BPM) measured using VScan Access R2 and Corometrics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GE Voluson P8 Confirmation of Visualization of Fetal Heart With Yes/No Answer Per Subject</measure>
    <time_frame>1 day - Up to 45 minutes of total scan time (5 minutes for this specific measurement)</time_frame>
    <description>Visualization of fetal heart as acquired from the GE Voluson P8 to verify that the fetal heart was correctly identified during the image acquisition using Vscan Access R2. This is gathered through a Yes/No confirmation by device operator as to whether it was the fetal heart being scanned (once for each subject).</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Adverse Events (AE/SAE) Reported During Study</measure>
    <time_frame>Collected from the time subject signs informed consent form to the time of completion of subject's scan session, estimated up to 4 hours</time_frame>
    <description>Summary of type and number of AEs, SAEs reported/recorded during course</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Scan Operators Who Completed Surveys Regarding Usability of Vscan Access R2 Device</measure>
    <time_frame>10 minute survey completed by scan operators upon completion their participation (only one day per user)</time_frame>
    <description>Series of nine questions regarding usability, ease of use, and workflow</description>
  </other_outcome>
  <other_outcome>
    <measure>Number of Device Issues/Complaints Reported by Site</measure>
    <time_frame>Three weeks (estimated study duration)</time_frame>
    <description>Device Issues, Complaints, and Malfunctions will be reported in a table (type and number)</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Gather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd Trimester</condition>
  <arm_group>
    <arm_group_label>VScan Access R2 Ultrasound System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GE VScan Access R2 Ultrasound System</intervention_name>
    <description>A diagnostic ultrasound imaging system manufactured by the study Sponsor.</description>
    <arm_group_label>VScan Access R2 Ultrasound System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GE Corometrics 170 Series Fetal Monitor</intervention_name>
    <description>A reference device to record a continuous fetal heart rate.</description>
    <arm_group_label>VScan Access R2 Ultrasound System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>GE Corometrics 170 Series Fetal Monitor</intervention_name>
    <description>A reference device for verification of scanning the fetal heart.</description>
    <arm_group_label>VScan Access R2 Ultrasound System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women aged 18 years or older at the time of consent;

          2. By self-report, are in the 2nd or 3rd trimester of pregnancy;

          3. Able and willing to provide written informed consent for participation;

          4. Provide a completed Healthcare Verification Form which confirms the subject has
             received at least one diagnostic ultrasound during this pregnancy and has an
             uncomplicated pregnancy.

        Exclusion Criteria:

          1. Are direct employees/contractors of General Electric (GE);

          2. Are potentially put at additional risk by participating, in the opinion of study
             staff;

          3. Twin pregnancies identified in patient medical history.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Study of pregnant volunteers</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>GE Healthcare - Milwaukee County Research Park</name>
      <address>
        <city>Wauwatosa</city>
        <state>Wisconsin</state>
        <zip>53226-4856</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>August 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2018</study_first_posted>
  <results_first_submitted>December 10, 2018</results_first_submitted>
  <results_first_submitted_qc>April 22, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 11, 2019</results_first_posted>
  <last_update_submitted>April 22, 2019</last_update_submitted>
  <last_update_submitted_qc>April 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 26, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/19/NCT03617419/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>VScan Access R2 Ultrasound System</title>
          <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Part 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Part 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Data and results collected/analyzed for participants in active study phase (2). Pilot participant data not collected per study Protocol.</population>
      <group_list>
        <group group_id="B1">
          <title>VScan Access R2 Ultrasound System</title>
          <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Trimester (2nd or 3rd)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>2nd Trimester of Pregnancy</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>3rd Trimester of Pregnancy</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Difference in Fetal Heart Rate as Measured by VScan Access R2 and Corometrics</title>
        <description>Absolute difference and variance in fetal heart rate (in BPM) measured using VScan Access R2 and Corometrics</description>
        <time_frame>1 day - Up to 45 minutes of total scan time</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VScan Access R2 Ultrasound System</title>
            <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Fetal Heart Rate as Measured by VScan Access R2 and Corometrics</title>
          <description>Absolute difference and variance in fetal heart rate (in BPM) measured using VScan Access R2 and Corometrics</description>
          <units>Beats Per Minute (BPM)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.2" spread="4.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>GE Voluson P8 Confirmation of Visualization of Fetal Heart With Yes/No Answer Per Subject</title>
        <description>Visualization of fetal heart as acquired from the GE Voluson P8 to verify that the fetal heart was correctly identified during the image acquisition using Vscan Access R2. This is gathered through a Yes/No confirmation by device operator as to whether it was the fetal heart being scanned (once for each subject).</description>
        <time_frame>1 day - Up to 45 minutes of total scan time (5 minutes for this specific measurement)</time_frame>
        <population>Subjects in Part 1 (2) and Part 2 (14)</population>
        <group_list>
          <group group_id="O1">
            <title>VScan Access R2 Ultrasound System</title>
            <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
          </group>
        </group_list>
        <measure>
          <title>GE Voluson P8 Confirmation of Visualization of Fetal Heart With Yes/No Answer Per Subject</title>
          <description>Visualization of fetal heart as acquired from the GE Voluson P8 to verify that the fetal heart was correctly identified during the image acquisition using Vscan Access R2. This is gathered through a Yes/No confirmation by device operator as to whether it was the fetal heart being scanned (once for each subject).</description>
          <population>Subjects in Part 1 (2) and Part 2 (14)</population>
          <units>&quot;Yes&quot; responses</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Adverse Events (AE/SAE) Reported During Study</title>
        <description>Summary of type and number of AEs, SAEs reported/recorded during course</description>
        <time_frame>Collected from the time subject signs informed consent form to the time of completion of subject's scan session, estimated up to 4 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VScan Access R2 Ultrasound System</title>
            <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Adverse Events (AE/SAE) Reported During Study</title>
          <description>Summary of type and number of AEs, SAEs reported/recorded during course</description>
          <units>AEs / SAEs Reported</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Scan Operators Who Completed Surveys Regarding Usability of Vscan Access R2 Device</title>
        <description>Series of nine questions regarding usability, ease of use, and workflow</description>
        <time_frame>10 minute survey completed by scan operators upon completion their participation (only one day per user)</time_frame>
        <population>Device Operators</population>
        <group_list>
          <group group_id="O1">
            <title>VScan Access R2 Ultrasound System</title>
            <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Scan Operators Who Completed Surveys Regarding Usability of Vscan Access R2 Device</title>
          <description>Series of nine questions regarding usability, ease of use, and workflow</description>
          <population>Device Operators</population>
          <units>Completed Usability Surveys</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Device Issues/Complaints Reported by Site</title>
        <description>Device Issues, Complaints, and Malfunctions will be reported in a table (type and number)</description>
        <time_frame>Three weeks (estimated study duration)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VScan Access R2 Ultrasound System</title>
            <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Device Issues/Complaints Reported by Site</title>
          <description>Device Issues, Complaints, and Malfunctions will be reported in a table (type and number)</description>
          <units>Device Malfunctions</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event collection period for duration of study scanning (~ one week).</time_frame>
      <desc>Subject were monitored for AEs, SAEs, and UADEs during their study exams, until they exited the exam area. Procedures were conducted during a single visit (about one hour for each subject).</desc>
      <group_list>
        <group group_id="E1">
          <title>VScan Access R2 Ultrasound System</title>
          <description>Pre-market: Vscan Access R2 Ultrasound System
The following post-market products will be used on label:
GE Corometrics 170 Series Fetal Monitor - as a reference for value of fetal heart rate GE Voluson P8 Ultrasound System - for verification of fetal location during measurement
GE VScan Access R2 Ultrasound System: A diagnostic ultrasound imaging system manufactured by the study Sponsor.
GE Corometrics 170 Series Fetal Monitor: A reference device to record a continuous fetal heart rate.
GE Corometrics 170 Series Fetal Monitor: A reference device for verification of scanning the fetal heart.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sr. Clinical Affairs Project Manager</name_or_title>
      <organization>GE Healthcare</organization>
      <phone>2624095722</phone>
      <email>kevin.r.siewert@ge.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

